Insider trades

Karas Eric

Karas Eric made 0 buys and 1 sale on the open market in the last 12 months at ARS Pharmaceuticals, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
ARS Pharmaceuticals, Inc.
NASDAQ:SPRY
Chief Commercial Officer12,176Jun 12, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
ARS Pharmaceuticals, Inc.
NASDAQ:SPRY
Jun 12, 2026Sale25,000US$10.00US$250K12,176Jun 12, 2026